← Back to Clinical Trials
Recruiting NCT06175650

NCT06175650 Towards a Sex-specific "Female Enhanced Recovery After Cardiac Surgery'' (F-ERAS) Pathway:

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06175650
Status Recruiting
Phase
Sponsor Jennifer Breel
Condition Female
Study Type OBSERVATIONAL
Enrollment 5,500 participants
Start Date 2023-11-21
Primary Completion 2025-11-21

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Cardiac surgery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 5,500 participants in total. It began in 2023-11-21 with a primary completion date of 2025-11-21.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to evaluate the differences between men and women undergoing cardiac surgery. We will look at perioperative factors such as body weight, body surface area, previous medical history, pharmacokinetics, transfusion, coagulation, cardiopulmonary bypass (CPB) related factors, cardiac function, inotropic requirements, risk, and outcome scores as well as morbidity and mortality at 30 and 90 days, 1, 5, and 10 years.

Eligibility Criteria

Inclusion Criteria: * Patients \> 18 years * All patients who underwent cardiac surgery from 1 January 2016 to the start of the study, in either of the centres (AMC or VUmc) (retrospective) * All patients undergoing cardiac surgery from the start of the study (\~March 2022) until approximately 2032 Exclusion Criteria: • Patients who object to the re-use of their care data or do not give consent

Contact & Investigator

Central Contact

Jennifer S Breel, MSc

✉ j.s.breel@amsterdamumc.nl

📞 +31610019257

Principal Investigator

Markus W Hollmann, Professor

PRINCIPAL INVESTIGATOR

Anesthesiology and Pain Medicine, Amsterdam Medical Center

Frequently Asked Questions

Who can join the NCT06175650 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06175650 currently recruiting?

Yes, NCT06175650 is actively recruiting participants. Contact the research team at j.s.breel@amsterdamumc.nl for enrollment information.

Where is the NCT06175650 trial being conducted?

This trial is being conducted at Amsterdam, Netherlands.

Who is sponsoring the NCT06175650 clinical trial?

NCT06175650 is sponsored by Jennifer Breel. The principal investigator is Markus W Hollmann, Professor at Anesthesiology and Pain Medicine, Amsterdam Medical Center. The trial plans to enroll 5,500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology